期刊文献+

雄激素受体基因新突变引起的完全型雄激素不敏感综合征 被引量:6

A novel mutation Glu441stop (GAA to TAA) of androgen receptor gene resulting in complete androgen insensitivity syndrome
原文传递
导出
摘要 目的 对1例完全型雄激素不敏感综合征(complete androgen insensitivity syndrom,CAIS)的雄激素受体(androgen receptor,AR)基因进行分析,寻找致病突变.方法 提取外周血全基因组DNA,扩增位于X染色体上的AR基因所有8个外显子及邻近外显子与内含子之间的剪切位点DNA序列,对扩增片段直接进行DNA序列测定,与基因库中的序列进行比对.结果 该病例AR基因第1外显子的441位密码子发生无义突变(GAA→TAA),由编码谷氨酸(Glu)变为终止密码,导致雄激素受体蛋白翻译至441位时终止,产生没有功能的氨基酸多肽残段.结论 Glu441stop(GAA→TAA)是一种导致CAIS的AR基因新的突变方式,之前在世界范围内均未见报道,丰富了AR基因突变谱,增加对CAIS发病机制的了解. Objective To identify the mutation of human androgen receptor gene(AR) in a patient with complete androgen insensitivity syndrome (CAIS). Methods DNA sequences of 8 exons and their exon/intron boundaries of the AR gene in the patient were amplified by PCR and directly sequenced. Results DNA sequencing revealed a nonsense mutation in exon 1, resulting in a change of codon 441 GAA (glutamic acid) to a stop codon (TAA). Conclusion A novel mutation Glu441stop (GAA to TAA) of the androgen receptor gene leading to complete androgen insensitivity syndrome was identified in this study in a Chinese patient. It may help us further understanding the pathogenesis of CAIS.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2011年第2期176-179,共4页 Chinese Journal of Medical Genetics
关键词 完全型雄激素不敏感综合征 雄激素受体 基因突变 complete androgen insensitivity syndrome androgen receptor gene mutation
  • 相关文献

参考文献2

共引文献5

同被引文献43

  • 1田秦杰,刘慧,郎景和.完全型雄激素不敏感综合征的临床特征与变异[J].中国实用妇科与产科杂志,2004,20(12):723-725. 被引量:21
  • 2田秦杰,黄尚志,郁琦,李辉,葛秦生.完全型雄激素不敏感综合征中雄激素受体基因突变的检测与分析[J].生殖医学杂志,1995,4(4):196-200. 被引量:11
  • 3Singh Rajender Lalji Singh Kumarasamy Thangaraj.Phenotypic heterogeneity of mutations in androgen receptor gene[J].Asian Journal of Andrology,2007,9(2):147-179. 被引量:23
  • 4Hughes IA, Houk C, Ahmed SF,et al. Consensus statement on management of intersex disorders. J Pediatr Urol, 2006,2 (3) : 148-162.
  • 5Pasterski V, Prentice P, Hughes IA. Impact of the consensus statement and the new DSD classification system. Best Pract Res Clin Endocrinol Metab, 2010,24 (2) : 187-195.
  • 6Sata F, Kurahashi N, Ban S, et al. Genetic polymorphisms of 1713-hydroxysteroid dehydrogenase 3 and the risk of hypospadias. J Sex Med, 2010,7(8) :2729-2738.
  • 7Bertelloni S,Maggio MC,Felerico G,et al. 17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to- female sex reversal. Gynecol Endocrinol,2006,22 (9) :488-494.
  • 8Mains LM, Vakili B, Lacassie Y, et al. 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil Steril,2008,89( 1 ) : 228.
  • 9Bachelot A, Chakhtoura Z, Kuttenn F, et al. 17 beta hydroxysteroid dehydrogenase deficiency caused by homozygous H271R mutation. European Society of Endocrinology, 8th European congress of Endocrinology, Glasgow, 2006, Boston: Endocrine, 2006: 156.
  • 10Welzel M, WUstemann N, Simic-Schleicher G, et al. Carboxyl- terminal mutations in 3beta-hydroxysteroid dehydrogenase type II cause severe salt-wasting congenital adrenal hyperplasia. J Clin Endocrinol Metab ,2008,93 (4) : 1418-1425.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部